NOVAST LABS FDA Approval ANDA 091247

ANDA 091247

NOVAST LABS

FDA Drug Application

Application #091247

Application Sponsors

ANDA 091247NOVAST LABS

Marketing Status

Prescription001

Application Products

001TABLET;ORAL-280.15MG,N/A;0.02MG,0.01MG0PIMTREADESOGESTREL; ETHINYL ESTRADIOL

FDA Submissions

ORIG1AP2013-08-01
LABELING; LabelingSUPPL2AP2017-08-09STANDARD
LABELING; LabelingSUPPL3AP2019-10-28STANDARD
LABELING; LabelingSUPPL8AP2020-12-31STANDARD
LABELING; LabelingSUPPL9AP2022-04-29STANDARD

Submissions Property Types

ORIG1Null17
SUPPL2Null7
SUPPL3Null7
SUPPL8Null7
SUPPL9Null7

TE Codes

001PrescriptionAB

CDER Filings

NOVAST LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91247
            [companyName] => NOVAST LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"PIMTREA","activeIngredients":"DESOGESTREL; ETHINYL ESTRADIOL","strength":"0.15MG,N\/A;0.02MG,0.01MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PIMTREA","submission":"DESOGESTREL; ETHINYL ESTRADIOL","actionType":"0.15MG,N\/A;0.02MG,0.01MG","submissionClassification":"TABLET;ORAL-28","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.